Opportunity
DIBBS #SPE2DP-26-T-4192
DLA Solicitation for MOXIFLOXACIN HYDROCHLO Pharmaceutical Product
Posted
July 20, 2026
Respond By
July 27, 2026
Identifier
SPE2DP-26-T-4192
NAICS
424210
The Defense Logistics Agency (DLA) is seeking to procure MOXIFLOXACIN HYDROCHLO, a pharmaceutical product, via solicitation SPE2DP-26-T-4192. - Government Buyer: - Defense Logistics Agency (DLA) - Solicitation managed through DIBBS portal - Products Requested: - MOXIFLOXACIN HYDROCHLO, NSN 6505-01-503-4772 - Quantity: 15 units - Approved OEMs and part numbers: - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Notable Requirements: - Only products from the specified OEMs and part numbers are approved - Opportunity is designated as a 'Fast Award' for expedited procurement - No unique technical requirements beyond sourcing from approved manufacturers
Description
MOXIFLOXACIN HYDROCHLO (QTY: 15, NSN: 6505-01-503-4772, Purchase Request: 7017524176) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.